Surv‐CRM‐12: A Bayesian phase I/II survival CRM for right‐censored toxicity endpoints with competing disease progression.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 5753, doi. 10.1002/sim.9591
- By:
- Publication type:
- Article
Works matching IS 02776715 AND DT 2022 AND VI 41 AND IP 29
Results: 11
1
2
A proper statistical inference framework to compare clinical trial and real‐world progression‐free survival data.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 5738, doi. 10.1002/sim.9590
- By:
- Publication type:
- Article
3
Multi‐threshold proportional hazards model and subgroup identification.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 5715, doi. 10.1002/sim.9589
- By:
- Publication type:
- Article
4
A flexible‐hazards cure model with application to patients with soft tissue sarcoma.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 5698, doi. 10.1002/sim.9588
- By:
- Publication type:
- Article
5
Estimating mixture effects and cumulative spatial risk over time simultaneously using a Bayesian index low‐rank kriging multiple membership model.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 5679, doi. 10.1002/sim.9587
- By:
- Publication type:
- Article
6
Conditional probability and ratio‐based approaches for mapping the coverage of multi‐dose vaccines.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 5662, doi. 10.1002/sim.9586
- By:
- Publication type:
- Article
7
Regression analysis for covariate‐adaptive randomization: A robust and efficient inference perspective.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 5645, doi. 10.1002/sim.9585
- By:
- Publication type:
- Article
8
Blinded sample size re‐estimation for comparing over‐dispersed count data incorporating follow‐up lengths.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 5622, doi. 10.1002/sim.9584
- By:
- Publication type:
- Article
9
A simulated maximum likelihood procedure for analyzing imprecise trade‐off thresholds between the benefits and harms of medicines.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 5612, doi. 10.1002/sim.9583
- By:
- Publication type:
- Article
10
A Bayesian multilevel time‐varying framework for joint modeling of hospitalization and survival in patients on dialysis.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 5597, doi. 10.1002/sim.9582
- By:
- Publication type:
- Article
11
Issue Information.
- Published in:
- Statistics in Medicine, 2022, v. 41, n. 29, p. 1, doi. 10.1002/sim.9071
- Publication type:
- Article